RxDoctor Payments DataLook up a doctor →

Jennifer Whitsell

Nurse Practitioner · Elizabethtown, KYNPI 1457809279

Payments from drug & device makers

$12,554in general payments, 2019–2025

Across 852 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Johnson & Johnson$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$987
  • Gilead$617
  • Sanofi$584
  • plus $4K from 31 others

What the payments were for

  • Food & beverage$12,513100%
  • Education$410%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,554 in reported general payments places this provider in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$63,146
Medicare patients
430
Services billed
800

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab15$408,160
OcalivaObeticholic Acid16$220,451
CreonLipase/Protease/Amylase54$202,059
Humira(Cf) PenAdalimumab22$148,958
XifaxanRifaximin35$111,626
LinzessLinaclotide73$78,047
ZenpepLipase/Protease/Amylase14$67,222
IbsrelaTenapanor Hcl30$53,135
MotegrityPrucalopride Succinate49$29,977
TrulancePlecanatide15$16,869
VoqueznaVonoprazan Fumarate13$10,965
MovantikNaloxegol Oxalate16$10,315
Dexlansoprazole DrDexlansoprazole41$8,703
Mesalamine ErMesalamine36$8,567
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates99$6,126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$1,307$408,16015 claims
AbbVieCreon, Linzess$3,203$280,106127 claims
Intercept Pharmaceuticals, Inc.Ocaliva$298$220,45116 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance, Plenvu$1,519$130,81166 claims
Aimmune Therapeutics, Inc.Zenpep$133$67,22214 claims
Ardelyx, Inc.Ibsrela$345$53,13530 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$987$29,97749 claims
Phathom Pharmaceuticals, Inc.Voquezna$245$10,96513 claims
Redhill Biopharma Inc.Movantik$118$10,31516 claims
Braintree Laboratories, Inc.Sutab$205$2,23414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Elizabethtown

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →